XML 222 R43.htm IDEA: XBRL DOCUMENT
v3.25.2

Discontinued Operations - Sale of VitaMedica (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Jun. 30, 2024
Discontinued Operations - Sale of VitaMedica |  |
Schedule of Discontinued Operations - Sale of VitaMedica |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, 2024 |  |  | March 31, 2024 |
Discontinued Operations |  |  |  |  |  |
Revenue |  | $ | 2,673,744 |  |  | $ | 6,708,021 |
Cost of sales |  | $ | 587,142 |  |  | $ | 1,480,486 |
Sales, general and administrative expenses |  | $ | 1,888,490 |  |  | $ | 4,694,350 |
Depreciation and amortization |  | $ | 115,896 |  |  | $ | 353,646 |
Income (loss) from discontinued operations |  | $ | 81,978 |  |  | $ | 239,908 |
Accounts receivable net of allowance for doubtful accounts |  | $ | 444,730 |  |  | $ | 444,730 |
Fixed assets, net of accumulated depreciation |  | $ | 54,791 |  |  | $ | 54,791 |
Total assets |  | $ | 4,901,950 |  |  | $ | 4,901,950 |
Total liabilities |  | $ | 403,460 |  |  | $ | 403,460 |
|  | Years ended June 30, |
|  | 2024 |  |  | 2023 |
Discontinued Operations |  |  |  |  |  |
Revenue |  | $ | 8,707,268 |  |  | $ | 7,610,949 |
Cost of sales |  | $ | 2,051,854 |  |  | $ | 1,362,036 |
Sales, general and administrative expenses |  | $ | 6,076,257 |  |  | $ | 5,891,301 |
Depreciation and amortization |  | $ | 425,263 |  |  | $ | 527,634 |
Other expenses |  | $ | (59,742 | ) |  | $ | 212,427 |
Income (loss) from discontinued operations |  | $ | 213,636 |  |  | $ | (382,449 | )
Accounts receivable net of allowance for doubtful accounts |  | $ | - |  |  | $ | 289,416 |
Fixed assets, net of accumulated depreciation |  | $ | - |  |  | $ | 83,840 |
Total assets |  | $ | - |  |  | $ | 4,875,757 |
Total liabilities |  | $ | - |  |  | $ |  |
Schedule of consideration paid fair value vita medica |  |
Cash |  | $ | 2,100.000 |
Reduction of liabilities |  |  | 1,900,000 |
Note payable |  |  | 1,000,000 |
Working capital payment |  |  | 1,000,000 |
|  | $ | 6,000,000 |
Recognized amounts of identifiable assets, liabilities and intangible assets transferred: |  |  |  |
Cash |  | $ | 37,267 |
Accounts receivable |  |  | 416,374 |
Inventory |  |  | 1,747,150 |
Prepaid expenses |  |  | 518,280 |
Fixed assets |  |  | 111,305 |
Other assets |  |  | 184,800 |
Liabilities |  |  | (512,926 | )
Total identifiable assets |  |  | 2,502,250 |
Total goodwill and intangible assets |  |  | 1,549,212 |
Total assets transferred |  |  | 4,051,462 |
Purchase price |  | $ | 6,000,000 |
Gain on sale of VitaMedica |  | $ | 1,948,538 |

X
- References No definition available. + Details
Name: | upxi_DiscontinuedOperationsSaleOfVitamedicaAbstract
Namespace Prefix: | upxi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | upxi_ScheduleOfConsiderationPaidFairValueVitaMedicaTableTextBlock
Namespace Prefix: | upxi_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | upxi_ScheduleOfDiscontinuedOperationsOfVitaMedicaTableTextBlock
Namespace Prefix: | upxi_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration